Expert Video - How is biomarker testing carried out?
Robert Winn, MD, of the Massey Cancer Center at Virginia Commonwealth University, discusses different ways to take samples for lung cancer biomarker testing, including VATS (video assisted thoracoscopy), bronchoscopy, and blood, urine, or saliva testing. He also discusses the number of different biomarkers a laboratory may look for in the biological samples and shares questions patients should ask before and after biomarker testing, including about insurance coverage, when to expect results, and when to call with questions.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Animation - Understanding Biomarker Testing in NSCLC
Slide Show - Understanding Biomarker Testing in NSCLC
1.
What is 'comprehensive biomarker testing'?
2.
What is a driver mutation?
3.
How is biomarker testing carried out?
4.
When should biomarker testing be done in NSCLC?
5.
Which biomarkers exist for NSCLC?
6.
What happens if my tumor tests positive? What happens if it doesn’t test positive for a biomarker?
7.
What if I have already had a biopsy and my tumor was not tested for biomarkers?
8.
What should newly diagnosed lung cancer patients do if biomarker testing is not offered to them?
9.
Why is biomarker testing so important for certain ethnic groups, such as African Americans?
10.
How can we close the gaps to make sure all NSCLC patients get tested?
